Ambulatory infusion centers provide convenient and cost-effective treatments to patients suffering from chronic diseases and disorders. These centers offer various therapies such as chemotherapy, pain management, antibiotic therapy, intravenous immunoglobulin, and others. Ambulatory infusion centers reduce the risk of hospital-acquired infections and provide comfortable treatment to patients. The global Ambulatory Infusion Center Market is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing geriatric population is one of the major factors driving the growth of the ambulatory infusion center market. As per the United Nations, the population aged 60 years or above is expected to double from 12% to 22% between 2015 and 2050. The aging population is more susceptible to chronic diseases such as cancer, diabetes, respiratory diseases, cardiovascular diseases, and others necessitating long-term IV treatment. According to estimates by the Centers for Disease Control and Prevention (CDC), around 60-65% of all US adults suffer from at least one chronic disease. The rising prevalence of chronic disorders has increased the demand for ambulatory infusion services globally. This has encouraged healthcare providers to invest in outpatient infusion services catering to patient needs.
Segment Analysis
The global ambulatory infusion center market is dominated by stand-alone infusion centers segment. Stand-alone infusion centers are not attached to any hospitals and solely involved in delivering outpatient infusion services. These centers provide convenient options for patients as they can visit these centers as per their comfort without hospital related formalities. Also, standalone centers offer a more flexible schedule and privacy which driving their demand over hospital based centers.
Key Takeaways
The Global Ambulatory Infusion Center Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market is anticipated to grow at a CAGR of 6.7% during the forecast period. By 2030, the size of ambulatory infusion center market is projected to reach US$ 118,084.69 Mn.
Regional analysis
North America region currently dominates the ambulatory infusion center market owing to growing preference for outpatient services. The United States accounts for the major share in the North America ambulatory infusion center market. Growing popularity of standalone infusion centers along with supportive reimbursement policies are fueling the market growth in the region. Europe is also expected to witness significant growth in the ambulatory infusion center market during the forecast period.
Key players
Key players operating in the ambulatory infusion center market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare. Option Care Health and PharmaScript collectively hold largest market share in the global ambulatory infusion center market.
Get More Insights Here
https://healthcarelatesteditionnews.blogspot.com/2023/12/ambulatory-infusion-centers-market.html
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian